首页|阿莫西林-克拉维酸钾序贯治疗反复下呼吸道感染患儿的疗效

阿莫西林-克拉维酸钾序贯治疗反复下呼吸道感染患儿的疗效

扫码查看
目的 观察阿莫西林-克拉维酸钾序贯治疗反复下呼吸道感染(recurrent lower respiratory tract infection,RLRTI)患儿的疗效及对潮气肺功能,血清白细胞介素-6(interleukin-6,IL-6)、白细胞介素-8(interleukin-8,IL-8)、白细胞介素-10(interleukin-10,IL-10)水平的影响。方法 纳入近 92例RLRTI患儿作为研究对象,用随机数字表法分为观察组和对照组,各 46例,应用阿莫西林-克拉维酸钾治疗。对照组静脉滴注 7~10 d,观察组序贯治疗(静脉滴注 3~5 d,口服混悬剂 4~5 d)。比较2组临床疗效、主要症状(发热、咳嗽、喘息和肺啰音)消失时间、白细胞计数(white blood cell count,WBC)恢复时间、住院时间;治疗前后潮气肺功能指标(潮气量、呼吸频率、吸气时间、呼气时间、吸呼比、达峰时间比和达峰容积比)、血清炎症因子(IL-6、IL-8和IL-10)水平,及治疗期间不良反应。结果 观察组的治疗总有效率高于对照组(P<0。05);观察组发热、咳嗽、喘息、肺啰音消失时间,WBC恢复时间及住院时间均短于对照组(P<0。05);2组呼吸频率均较治疗前下降(P<0。05),吸气时间、呼气时间、达峰时间比、达峰容积比均较治疗前升高(P<0。05),且观察组达峰时间比、达峰容积比均高于对照组(P<0。05);2组血清IL-6、IL-8水平均较治疗前降低(P<0。05),且观察组低于对照组(P<0。05);IL-10水平均较治疗前升高(P<0。05),且观察组高于对照组(P<0。05);2组治疗期间不良反应发生率比较差异无统计学意义(P>0。05)。结论 阿莫西林-克拉维酸钾序贯治疗小儿RLRTI可促进症状恢复,改善潮气肺功能,提高疗效,机制可能与其调节IL-6、IL-8、IL-10等炎症细胞因子的表达水平有关。
Efficacy of amoxicillin-clavulanate potassium sequential therapy on children with recurrent lower respiratory tract infection
Objective To observe the efficacy of amoxicillin-clavulanate potassium sequential therapy on recurrent lower respiratory tract infection(RLRTI)in children and the influence on tidal pulmonary function and serum levels of interleukin-6(IL-6),interleukin-8(IL-8)and interleukin-10(IL-10).Methods 92 children with RLRTI were enrolled as the research subjects,and were divided into observation group and control group by random number table method,with 46 cases in each group.The above patients were treated with amoxicillin-clavulanate potassium,and the control group was given intravenous infusion for 7 to 10 days,and the observation group was given sequential therapy regimen(intravenous infusion for 3 to 5 days,and oral administration of suspension for 4 to 5 days).The clinical efficacy,disappearance times of main symptoms(fever,cough,wheezing and pulmonary rales),recovery time of white blood cell count(WBC),hospital stay,tidal pulmonary function(tidal volume,respiratory rate,inspiratory time,expiratory time,inspiratory-expiratory ratio,peak-to-peak time ratio and peak-to-peak volume ratio),the levels of serum inflammatory factors(IL-6,IL-8 and IL-10)before and after treatment and the occurrence of adverse reactions during treatment were compared between the 2 groups.Results The total effective rate of treatment in observation group was higher than that in control group(P<0.05).The disappearance times of fever,cough,wheezing and pulmonary rales,WBC recovery time and hospital stay in observation group were shorter than those in control group(P<0.05).The respiratory frequency of the 2 groups was decreased compared with that before treatment(P<0.05)while the inspiratory time,expiratory time,peak-to-peak time ratio and peak-to-peak volume ratio were increased compared with those before treatment(P<0.05),and the peak-to-peak time ratio and peak-to-peak volume ratio in observation group were higher than those in control group(P<0.05).The levels of serum IL-6 and IL-8 in both groups were reduced compared with before treatment(P<0.05),and the levels in observation group were lower than those in control group(P<0.05).The IL-10 level was enhanced compared with that before treatment(P<0.05),and the level in observation group was higher than that in control group(P<0.05).There was no statistical difference in the incidence rate of adverse reactions between the 2 groups during treatment(P>0.05).Conclusion Amoxicillin-clavulanate potassium sequential therapy for children with RLRTI can promote the symptom recovery,improve the tidal pulmonary function and enhance the efficacy,and its mechanism may be related to the regulations of expressions of IL-6,IL-8,IL-10 and other inflammatory factors.

amoxicillin-clavulanate potassiumsequential therapyrecurrent lower respiratory tract infectiontidal pulmonary functioninflammatory factors

章玲玲、闫燕

展开 >

黄山首康医院儿科,黄山 234000

阿莫西林-克拉维酸钾 序贯治疗 反复下呼吸道感染 潮气肺功能 炎症因子

安徽省自然科学基金项目

202011921

2024

西北药学杂志
西安交通大学,陕西省药学会

西北药学杂志

CSTPCD
影响因子:0.912
ISSN:1004-2407
年,卷(期):2024.39(3)
  • 20